Article
INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery
21 Oct 2016
Abstract excerpt
Motivation: While high-throughput sequencing (HTS) has been used successfully to discover tumor-specific mutant peptides (neoantigens) from somatic missense mutations, the field currently lacks a method for identifying which gene fusions may generate neoantigens. Results: We demonstrate the application of our gene fusion neoantigen discovery pipeline, called INTEGRATE-Neo, by identifying gene fusions in prostate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
